Sign in
CompletedNo phase

H. Pylori Infection and AIP Levels

Key facts

Who runs it
Tanta University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
300 people enrolled
Started
2 Jan 2025
Ended
4 Aug 2025
Type of study
Observational, 2 groups
Treatments tested
  • urea breath test
Record updated
29 December 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Patients older than 18 years
  • Able to sign the written consent
  • Willing to participate in the research and undergo H. pylori testing. Exclusion criteria
  • Unwilling to participate in the study
  • History of severe metabolic disorders
  • Taking medications that affect adipose tissue metabolism
  • History of gastric surgery

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Helicobacter pylori is a common bacterial infection of the stomach that can cause ulcers and other digestive problems. Recent studies suggest that this infection may also affect metabolism and blood fats (lipids), which are important for heart health. Changes in lipid levels, such as higher triglycerides and lower "good" cholesterol (HDL), can increase the risk of cardiovascular disease.

Read full original descriptionShow less

This study will examine whether H. pylori infection is linked to changes in lipid profiles, especially the Atherogenic Index of Plasma (AIP). AIP is a calculation based on triglycerides and HDL cholesterol that helps predict the risk of heart disease.

The 2 groups in the trial

  • Group 1A: H. pylori Positive - Normal AIP Group 1B: H. pylori Positive - Elevated AIP Group 2: H.

    Treatment: urea breath test

  • Group 1A: H. pylori Positive - Normal AIP, 1B: H. pylori Positive - Elevated AIP, Group 2: H.

    Treatment: urea breath test

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Helicobacter Pylori Infection as A Potential Risk Factor for Dyslipidemia: Insights From Atherogenic Index of Plasma (AIP)
Record updated
29 December 2025